+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Osteoarthritis Injectable Market Size, Share & Trends Analysis Report by Injection Type, Anatomy, End Use, and Growth Forecasts, 2026-2033- Product Image
Osteoarthritis Injectable Market Size, Share & Trends Analysis Report by Injection Type, Anatomy, End Use, and Growth Forecasts, 2026-2033- Product Image
New

Osteoarthritis Injectable Market Size, Share & Trends Analysis Report by Injection Type, Anatomy, End Use, and Growth Forecasts, 2026-2033

  • PDF Icon

    Report

  • 137 Pages
  • April 2026
  • Region: Global
  • Grand View Research
  • ID: 5983000
REQUEST CUSTOMIZATION
Description Jump to:
The global osteoarthritis injectable market size was valued at USD 8.18 billion in 2025 and is projected to reach USD 14.16 billion by 2033, growing at a CAGR of 7.17% from 2026 to 2033. This growth is primarily driven by the increasing prevalence of osteoarthritis (OA), particularly among the aging population, as well as rising awareness of minimally invasive treatment options.

Additionally, advancements in biologic therapies and next-generation injectable, along with supportive reimbursement policies in key regions, are expected to further propel market expansion over the forecast period. R&D activities in injectable osteoarthritis therapies are accelerating due to challenges in delivering drugs into dense joint tissues. Companies are focusing on intra-articular biologics and disease-modifying agents. Candidates like lorecivivint from Biosplice Therapeutics and TPX-100 from OrthoTrophix highlight ongoing innovation. For instance, in January 2026, Biosplice Therapeutics submitted a New Drug Application (NDA) to the U.S. FDA for lorecivivint, an intra-articular injection for knee osteoarthritis, which showed promising Phase III results for pain reduction and functional improvement.

Similarly, in March 2026, OrthoTrophix advanced its Phase 2b clinical trial of TPX-100 by completing patient enrollment, reinforcing its position in developing disease-modifying intra-articular therapies targeting cartilage regeneration in osteoarthritis. The growing emphasis on personalized medicine is reshaping the OA injectable market, with a greater focus on patient-specific biologics and regenerative therapies. Research from Columbia University on cartilage-regenerating stem cells highlights the potential for precision-based injectable treatments targeting early-stage disease progression.

Global Osteoarthritis Injectable Market Repoprt Segmentation

This report forecasts revenue growth at, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, the analyst has segmented the global osteoarthritis injectable market report on the basis of injection type, anatomy, end use, and region:

Injection Type Outlook (Revenue, USD Million, 2021-2033)

  • Hyaluronic Acid Injections
  • Corticosteroid Injections
  • Platelet-rich Plasma (PRP) Injections
  • Placental Tissue Matrix (PTM) Injections
  • Acetylsalicylic Acid (ASA) Injections
  • Others

Anatomy Outlook (Revenue, USD Million, 2021-2033)

  • Knee Osteoarthritis
  • Hip Osteoarthritis
  • Hand Osteoarthritis
  • Others

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Injection Type
1.2.2. Anatomy
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Injection Type
2.2.2. End Use
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Global Osteoarthritis Injectable Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Global Osteoarthritis Injectable Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. Pricing Analysis
Chapter 4. Global Osteoarthritis Injectable Market: Injection Type Estimates & Trend Analysis
4.1. Injection Type Market Share, 2025 & 2033
4.2. Segment Dashboard
4.3. Global Osteoarthritis Injectable Market by Injection Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
4.4.1. Hyaluronic Acid Injections
4.4.2. Corticosteroid Injections
4.4.3. Platelet-rich Plasma (PRP) Injections
4.4.4. Placental Tissue Matrix (PTM) Injections
4.4.5. Acetylsalicylic Acid (ASA) Injections
4.4.6. Others
Chapter 5. Global Osteoarthritis Injectable Market: Anatomy Estimates & Trend Analysis
5.1. Anatomy Market Share, 2025 & 2033
5.2. Segment Dashboard
5.3. Global Osteoarthritis Injectable Market by Anatomy Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
5.4.1. Knee Osteoarthritis
5.4.2. Hip Osteoarthritis
5.4.3. Hand Osteoarthritis
5.4.4. Others
Chapter 6. Global Osteoarthritis Injectable Market: End Use Estimates & Trend Analysis
6.1. End Use Market Share, 2025 & 2033
6.2. Segment Dashboard
6.3. Global Osteoarthritis Injectable Market by End Use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
6.4.1. Hospital Pharmacies
6.4.2. Retail Pharmacies
6.4.3. Others
Chapter 7. Global Osteoarthritis Injectable Market: Regional Estimates & Trend Analysis by
7.1. Regional Market Dashboard
7.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
7.3. North America
7.3.1. U.S.
7.3.2. Canada
7.3.3. Mexico
7.4. Europe
7.4.1. UK
7.4.2. Germany
7.4.3. France
7.4.4. Italy
7.4.5. Spain
7.4.6. Norway
7.4.7. Sweden
7.4.8. Denmark
7.5. Asia-Pacific
7.5.1. Japan
7.5.2. China
7.5.3. India
7.5.4. Australia
7.5.5. South Korea
7.5.6. Thailand
7.6. Latin America
7.6.1. Brazil
7.6.2. Argentina
7.7. MEA
7.7.1. South Africa
7.7.2. Saudi Arabia
7.7.3. UAE
7.7.4. Kuwait
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, by Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2025
8.3.4. Anika Therapeutics, Inc.
8.3.5. Bioventus.
8.3.6. Ferring Pharmaceuticals Inc.
8.3.7. Sanofi S.A.
8.3.8. Flexion Therapeutics, Inc.
8.3.9. Zimmer Biomet
8.3.10. Arthrex, Inc.
8.3.11. Royal Biologics
8.3.12. Teva Pharmaceutical Industries Ltd.
Chapter 9. Conclusion and Analyst Perspective
List of Tables
Table 1 List of key distributors and channel partners
Table 2 List of key emerging companies’/technology disruptors/innovators
Table 3 North America Osteoarthritis injectable Market, by country, 2021-2033 (USD Billion)
Table 4 North America Osteoarthritis injectable Market, by Injection Type, 2021-2033 (USD Billion)
Table 5 North America Osteoarthritis injectable Market, by Anatomy, 2021-2033 (USD Billion)
Table 6 North America Osteoarthritis injectable Market, by End Use, 2021-2033 (USD Billion)
Table 7 U.S. Osteoarthritis injectable Market, by Injection Type, 2021-2033 (USD Billion)
Table 8 U.S. Osteoarthritis injectable Market, by Anatomy, 2021-2033 (USD Billion)
Table 9 U.S. Osteoarthritis injectable Market, by End Use, 2021-2033 (USD Billion)
Table 10 Canada Osteoarthritis injectable Market, by Injection Type, 2021-2033 (USD Billion)
Table 11 Canada Osteoarthritis injectable Market, by Anatomy, 2021-2033 (USD Billion)
Table 12 Canada Osteoarthritis injectable Market, by End Use, 2021-2033 (USD Billion)
Table 13 Mexico Osteoarthritis injectable Market, by Injection Type, 2021-2033 (USD Billion)
Table 14 Mexico Osteoarthritis injectable Market, by Anatomy, 2021-2033 (USD Billion)
Table 15 Mexico Osteoarthritis injectable Market, by End Use, 2021-2033 (USD Billion)
Table 16 Europe Osteoarthritis injectable Market, by country, 2021-2033 (USD Billion)
Table 17 Europe Osteoarthritis injectable Market, by Injection Type, 2021-2033 (USD Billion)
Table 18 Europe Osteoarthritis injectable Market, by Anatomy, 2021-2033 (USD Billion)
Table 19 Europe Osteoarthritis injectable Market, by End Use, 2021-2033 (USD Billion)
Table 20 Germany Osteoarthritis injectable Market, by Injection Type, 2021-2033 (USD Billion)
Table 21 Germany Osteoarthritis injectable Market, by Anatomy, 2021-2033 (USD Billion)
Table 22 Germany Osteoarthritis injectable Market, by End Use, 2021-2033 (USD Billion)
Table 23 UK Osteoarthritis injectable Market, by Injection Type, 2021-2033 (USD Billion)
Table 24 UK Osteoarthritis injectable Market, by Anatomy, 2021-2033 (USD Billion)
Table 25 UK Osteoarthritis injectable Market, by End Use, 2021-2033 (USD Billion)
Table 26 France Osteoarthritis injectable Market, by Injection Type, 2021-2033 (USD Billion)
Table 27 France Osteoarthritis injectable Market, by Anatomy, 2021-2033 (USD Billion)
Table 28 France Osteoarthritis injectable Market, by End Use, 2021-2033 (USD Billion)
Table 29 Italy Osteoarthritis injectable Market, by Injection Type, 2021-2033 (USD Billion)
Table 30 Italy Osteoarthritis injectable Market, by Anatomy, 2021-2033 (USD Billion)
Table 31 Italy Osteoarthritis injectable Market, by End Use, 2021-2033 (USD Billion)
Table 32 Spain Osteoarthritis injectable Market, by Injection Type, 2021-2033 (USD Billion)
Table 33 Spain Osteoarthritis injectable Market, by Anatomy, 2021-2033 (USD Billion)
Table 34 Spain Osteoarthritis injectable Market, by End Use, 2021-2033 (USD Billion)
Table 35 Denmark Osteoarthritis injectable Market, by Injection Type, 2021-2033 (USD Billion)
Table 36 Denmark Osteoarthritis injectable Market, by Anatomy, 2021-2033 (USD Billion)
Table 37 Denmark Osteoarthritis injectable Market, by End Use, 2021-2033 (USD Billion)
Table 38 Sweden Osteoarthritis injectable Market, by Injection Type, 2021-2033 (USD Billion)
Table 39 Sweden Osteoarthritis injectable Market, by Anatomy, 2021-2033 (USD Billion)
Table 40 Sweden Osteoarthritis injectable Market, by End Use, 2021-2033 (USD Billion)
Table 41 Norway Osteoarthritis injectable Market, by Injection Type, 2021-2033 (USD Billion)
Table 42 Norway Osteoarthritis injectable Market, by Anatomy, 2021-2033 (USD Billion)
Table 43 Norway Osteoarthritis injectable Market, by End Use, 2021-2033 (USD Billion)
Table 44 Asia-Pacific Osteoarthritis injectable Market, by country, 2021-2033 (USD Billion)
Table 45 Asia-Pacific Osteoarthritis injectable Market, by Injection Type, 2021-2033 (USD Billion)
Table 46 Asia-Pacific Osteoarthritis injectable Market, by Anatomy, 2021-2033 (USD Billion)
Table 47 Asia-Pacific Osteoarthritis injectable Market, by End Use, 2021-2033 (USD Billion)
Table 48 Japan Osteoarthritis injectable Market, by Injection Type, 2021-2033 (USD Billion)
Table 49 Japan Osteoarthritis injectable Market, by Anatomy, 2021-2033 (USD Billion)
Table 50 Japan Osteoarthritis injectable Market, by End Use, 2021-2033 (USD Billion)
Table 51 China Osteoarthritis injectable Market, by Injection Type, 2021-2033 (USD Billion)
Table 52 China Osteoarthritis injectable Market, by Anatomy, 2021-2033 (USD Billion)
Table 53 China Osteoarthritis injectable Market, by End Use, 2021-2033 (USD Billion)
Table 54 India Osteoarthritis injectable Market, by Injection Type, 2021-2033 (USD Billion)
Table 55 India Osteoarthritis injectable Market, by Anatomy, 2021-2033 (USD Billion)
Table 56 India Osteoarthritis injectable Market, by End Use, 2021-2033 (USD Billion)
Table 57 Australia Osteoarthritis injectable Market, by Injection Type, 2021-2033 (USD Billion)
Table 58 Australia Osteoarthritis injectable Market, by Anatomy, 2021-2033 (USD Billion)
Table 59 Australia Osteoarthritis injectable Market, by End Use, 2021-2033 (USD Billion)
Table 60 South Korea Osteoarthritis injectable Market, by Injection Type, 2021-2033 (USD Billion)
Table 61 South Korea Osteoarthritis injectable Market, by Anatomy, 2021-2033 (USD Billion)
Table 62 South Korea Osteoarthritis injectable Market, by End Use, 2021-2033 (USD Billion)
Table 63 Thailand Osteoarthritis injectable Market, by Injection Type, 2021-2033 (USD Billion)
Table 64 Thailand Osteoarthritis injectable Market, by Anatomy, 2021-2033 (USD Billion)
Table 65 Thailand Osteoarthritis injectable Market, by End Use, 2021-2033 (USD Billion)
Table 66 Latin America Osteoarthritis injectable Market, by country, 2021-2033 (USD Billion)
Table 67 Latin America Osteoarthritis injectable Market, by Injection Type, 2021-2033 (USD Billion)
Table 68 Latin America Osteoarthritis injectable Market, by Anatomy, 2021-2033 (USD Billion)
Table 69 Latin America Osteoarthritis injectable Market, by End Use, 2021-2033 (USD Billion)
Table 70 Brazil Osteoarthritis injectable Market, by Injection Type, 2021-2033 (USD Billion)
Table 71 Brazil Osteoarthritis injectable Market, by Anatomy, 2021-2033 (USD Billion)
Table 72 Brazil Osteoarthritis injectable Market, by End Use, 2021-2033 (USD Billion)
Table 73 Argentina Osteoarthritis injectable Market, by Injection Type, 2021-2033 (USD Billion)
Table 74 Argentina Osteoarthritis injectable Market, by Anatomy, 2021-2033 (USD Billion)
Table 75 Argentina Osteoarthritis injectable Market, by End Use, 2021-2033 (USD Billion)
Table 76 MEA Osteoarthritis injectable Market, by country, 2021-2033 (USD Billion)
Table 77 MEA Osteoarthritis injectable Market, by Injection Type, 2021-2033 (USD Billion)
Table 78 MEA Osteoarthritis injectable Market, by Anatomy, 2021-2033 (USD Billion)
Table 79 MEA Osteoarthritis injectable Market, by End Use, 2021-2033 (USD Billion)
Table 80 South Africa Osteoarthritis injectable Market, by Injection Type, 2021-2033 (USD Billion)
Table 81 South Africa Osteoarthritis injectable Market, by Anatomy, 2021-2033 (USD Billion)
Table 82 South Africa Osteoarthritis injectable Market, by End Use, 2021-2033 (USD Billion)
Table 83 Saudi Arabia Osteoarthritis injectable Market, by Injection Type, 2021-2033 (USD Billion)
Table 84 Saudi Arabia Osteoarthritis injectable Market, by Anatomy, 2021-2033 (USD Billion)
Table 85 Saudi Arabia Osteoarthritis injectable Market, by End Use, 2021-2033 (USD Billion)
Table 86 UAE Osteoarthritis injectable Market, by Injection Type, 2021-2033 (USD Billion)
Table 87 UAE Osteoarthritis injectable Market, by Anatomy, 2021-2033 (USD Billion)
Table 88 UAE Osteoarthritis injectable Market, by End Use, 2021-2033 (USD Billion)
Table 89 Kuwait Osteoarthritis injectable Market, by Injection Type, 2021-2033 (USD Billion)
Table 90 Kuwait Osteoarthritis injectable Market, by Anatomy, 2021-2033 (USD Billion)
Table 91 Kuwait Osteoarthritis injectable Market, by End Use, 2021-2033 (USD Billion)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Market formulation & validation
Figure 8 Global osteoarthritis injectable market: market outlook
Figure 9 Global Osteoarthritis Injectable competitive insights
Figure 10 Parent market outlook
Figure 11 Related/ancillary market outlook
Figure 12 Penetration and growth prospect mapping
Figure 13 Industry value chain analysis
Figure 14 Global osteoarthritis injectable market driver impact
Figure 15 Global osteoarthritis injectable market restraint impact
Figure 16 Global osteoarthritis injectable market strategic initiatives analysis
Figure 17 Global osteoarthritis injectable market: Injection Type movement analysis
Figure 18 Global osteoarthritis injectable market: Injection Type outlook and key takeaways
Figure 19 Hyaluronic Acid Injections market estimates and forecast, 2021-2033 (USD Billion)
Figure 20 Corticosteroid Injections market estimates and forecast, 2021-2033 (USD Billion)
Figure 21 Platelet-rich Plasma (PRP) Injections market estimates and forecast, 2021-2033 (USD Billion)
Figure 22 Placental Tissue Matrix (PTM) Injections market estimates and forecast, 2021-2033 (USD Billion)
Figure 23 Acetylsalicylic Acid (ASA) Injections market estimates and forecast, 2021-2033 (USD Billion)
Figure 24 Others market estimates and forecast, 2021-2033 (USD Billion)
Figure 25 Global osteoarthritis injectable market: Anatomy movement analysis
Figure 26 Global osteoarthritis injectable market: Anatomy outlook and key takeaways
Figure 27 Knee Osteoarthritis market estimates and forecasts, 2021-2033 (USD Billion)
Figure 28 Hip Osteoarthritis market estimates and forecasts, 2021-2033 (USD Billion)
Figure 29 Hand Osteoarthritis market estimates and forecasts, 2021-2033 (USD Billion)
Figure 30 Others market estimates and forecasts, 2021-2033 (USD Billion)
Figure 31 Global osteoarthritis injectable market: End Use movement analysis
Figure 32 Global osteoarthritis injectable market: End Use outlook and key takeaways
Figure 33 Hospital Pharmacies market estimates and forecasts, 2021-2033 (USD Billion)
Figure 34 Retail Pharmacies market estimates and forecasts, 2021-2033 (USD Billion)
Figure 35 Others market estimates and forecasts, 2021-2033 (USD Billion)
Figure 36 Market share of key market players- Global osteoarthritis injectable market
Figure 37 North America market size, & forecasts and trend analysis, 2021 to 2033 (USD Billion)
Figure 38 U.S. market size, & forecasts and trend analysis, 2021 to 2033 (USD Billion)
Figure 39 Canada market size, & forecasts and trend analysis, 2021 to 2033 (USD Billion)
Figure 40 Mexico market size, & forecasts and trend analysis, 2021 to 2033 (USD Billion)
Figure 41 Europe market size, & forecasts and trend analysis, 2021 to 2033 (USD Billion)
Figure 42 UK market size, & forecasts and trend analysis, 2021 to 2033 (USD Billion)
Figure 43 Germany market size, & forecasts and trend analysis, 2021 to 2033 (USD Billion)
Figure 44 Spain market size, & forecasts and trend analysis, 2021 to 2033 (USD Billion)
Figure 45 France market size, & forecasts and trend analysis, 2021 to 2033 (USD Billion)
Figure 46 Italy market size, & forecasts and trend analysis, 2021 to 2033 (USD Billion)
Figure 47 Sweden market size, & forecasts and trend analysis, 2021 to 2033 (USD Billion)
Figure 48 Denmark market size, & forecasts and trend analysis, 2021 to 2033 (USD Billion)
Figure 49 Norway market size, & forecasts and trend analysis, 2021 to 2033 (USD Billion)
Figure 50 Asia-Pacific market size, & forecasts and trend analysis, 2021 to 2033 (USD Billion)
Figure 51 China market size, & forecasts and trend analysis, 2021 to 2033 (USD Billion)
Figure 52 Japan market size, & forecasts and trend analysis, 2021 to 2033 (USD Billion)
Figure 53 India market size, & forecasts and trend analysis, 2021 to 2033 (USD Billion)
Figure 54 Australia market size, & forecasts and trend analysis, 2021 to 2033 (USD Billion)
Figure 55 South Korea market size, & forecasts and trend analysis, 2021 to 2033 (USD Billion)
Figure 56 Thailand market size, & forecasts and trend analysis, 2021 to 2033 (USD Billion)
Figure 57 Latin America market size, & forecasts and trend analysis, 2021 to 2033 (USD Billion)
Figure 58 Brazil market size, & forecasts and trend analysis, 2021 to 2033 (USD Billion)
Figure 59 Argentina market size, & forecasts and trend analysis, 2021 to 2033 (USD Billion)
Figure 60 Middle East and Africa market size, & forecasts and trend analysis, 2021 to 2033 (USD Billion)
Figure 61 South Africa market size, & forecasts and trend analysis, 2021 to 2033 (USD Billion)
Figure 62 Saudi Arabia market size, & forecasts and trend analysis, 2021 to 2033 (USD Billion)
Figure 63 UAE market size, & forecasts and trend analysis, 2021 to 2033 (USD Billion)
Figure 64 Kuwait market size, & forecasts and trend analysis, 2021 to 2033 (USD Billion)

Companies Mentioned

  • Anika Therapeutics, Inc.
  • Bioventus.
  • Ferring Pharmaceuticals Inc.
  • Sanofi S.A.
  • Flexion Therapeutics, Inc.
  • Zimmer Biomet
  • Arthrex, Inc.
  • Royal Biologics
  • Teva Pharmaceutical Industries Ltd.

Table Information

Report AttributeDetails
No. of Pages137
PublishedApril 2026
Forecast Period2025 - 2033
Estimated Market Value ( USD ) in 2025 $ 8.18 Billion
Forecasted Market Value ( USD ) by 2033 $ 14.16 Billion
Compound Annual Growth Rate7.1%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Osteoarthritis Injectables - Global Strategic Business Report - Product Image

Osteoarthritis Injectables - Global Strategic Business Report

  • Report
  • 612 Pages
  • Global
From
Osteoarthritis Injectables Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Image

Osteoarthritis Injectables Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Joint Pain Injections Market - Global Forecast 2026-2032 - Product Image

Joint Pain Injections Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Sodium Hyaluronate Intra-Articular Injection Market - Global Forecast 2025-2030 - Product Image

Sodium Hyaluronate Intra-Articular Injection Market - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Sodium Hyaluronate Injection for Osteoarthritis Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Sodium Hyaluronate Injection for Osteoarthritis Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 112 Pages
  • Global
From

About the Osteoarthritis Injectables Market

In the medical industry, the osteoarthritis (OA) injectables market is an important segment within the broader category of infusions and injectables, which includes a wide range of medications administered through injections to treat various conditions. OA injectables are specifically designed to target osteoarthritis, a degenerative joint disease characterized by the breakdown of cartilage and underlying bone. The treatments in this market aim to alleviate symptoms such as pain, swelling, and improve joint function. These injectables are often hyaluronic acid-based viscosupplements or corticosteroids, intended for intra-articular administration. The OA injectables market is influenced by factors such as the prevalence of OA among the aging population, advancements in injection technology, and the development of new therapeutic agents that promise longer-lasting relief and potentially disease-modifying actions. Several companies are prominently involved in the osteoarthritis injectables market. Some of the key players include Sanofi, which offers Synvisc and Synvisc-One (hylan G-F 20), and the Anika Therapeutics, which markets products such as Monovisc and Orthovisc. Pfizer is known for its product Celebrex, while Johnson & Johnson markets the drug Euflexxa. Zimmer Biomet, a company that has a portfolio of joint preservation and restoration products, offers the injectable Gel-One. These companies, among others, are continually engaged in research and development to improve and expand their offerings in the OA injectables space Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.